Nanoscribe partners with Advanced BioMatrix to offer 4 new bioresins for Quantum X bio

FHS
May 16, 2024
6:49 am

Nanoscribe and Advanced BioMatrix have joined forces to pioneer the field of bioprinting with the launch of four advanced bioresins tailored for Two-Photon Polymerization (2PP) based 3D printing.

Otsuka cuts development for AVP-786 following Phase III flop – Pharmaceutical Technology

Otsuka Pharmaceuticals ended clinical development for AVP-786 for agitation associated with Alzheimer’s disease following a negative Phase III readout. Credit: SOPA Images via Getty Images.

May 23, 2024

“Alkaline water” fails to be an effective alternative for prevention of recurrent urinary stones

Bottled water marketed as “alkaline water” is unlikely to be an effective alternative for prevention of recurrent urinary stones, reports a study in the January

January 11, 2024

MUSC researchers uncover the surprising role of the dorsal peduncular nucleus in opioid addiction

Opioids, like the commonly prescribed pain reliever oxycodone, are known for being highly addictive. In 2022, nearly 85,000 people died from an opioid overdose in

August 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.